Aquestive Therapeutics (AQST): Operatsion rentabellik

Aquestive Corp (AQST) - korporativ logo

Aquestive Therapeutics (AQST) dividendlar to'lamaydi, buning o'rniga barqaror talab bilan xarakterlanadigan defensiv epilepsiya terapiyasi segmentiga e'tibor qaratadi. GURU.Markets platformasida operatsion marja egri chizig' ishonch ko'rsatkichi vazifasini bajaradi va ushbu metrika hozirda -114.10 darajasida turibdi. Biznesning o'sishi hamkorlar uchun ekotizim yaratuvchi mualliflikka oid PharmFilm eruvchan plyonkalariga tayanadi, shu bilan birga kompaniya logistikani optimallashtirish uchun tashqi pudratchilar tarmog'ini faol ravishda kengtirmoqda.

AQST - aquestive.com Operatsion foyda koeffitsiyenti 04.07.2022 - 20.11.2026 oraligʻida

Aquestive Therapeutics (AQST) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:Aquestive Pharma
Aquestive Corp brendining mahsuloti

Operatsion marja tushumga nisbatan asosiy biznes jarayonlaridan foyda olish samaradorligini o'lchaydi. Operatsion marja ko'rsatkichi alfa omilining dinamikasini vizuallashtiradi, bunda ekstremal qiymatlar yaqinlashayotgan tebranishlar haqida signal beradi. Ushbu metrika operatsion daromadning savdolarga nisbatidagi ko'rsatkichi sifatida hisoblanadi va ichki rentabellikni aks ettiradi. Ushbu ko'rsatkichning yuqori sezgirligi Aquestive Therapeutics (AQST) uchun juda muhimdir. Bu ulkan R&D xarajatlari va PharmFilm plyonkalarining FDA tomonidan qat'iy nazorat qilinishi bilan bog'liq.

Aquestive Therapeutics raqobatchilari tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.